The 2012 New York ASCO Checklist
FDA Panel Narrowly Rejects Xarelto for ACS
Individual Health Policies Fall Short, a Study Finds
First Cancer-Specific ACO Launches
GOP Mixed on Health Moves
Gains in Health System Seen as Lasting by Some
Consumer-Directed Health Plans Shown to be Money-Savers
Docs Need Primer on Long-Term Effects of Chemotherapy
Study: Rising Prices Drove Higher Spending Among Commercially Insured
FDA's $6.4 Billion Plan for Quick Reviews Moves to Senate
Health Insurance Exchanges Still Being Debated
Study: Healthcare Costs on Rise
Medicaid Primary Care Pay: The Next SGR?
Bracing for a Crash While IT Outages are Rare, Providers Need a Plan
ASCO '12 Abstract Dump: Cancer Stocks in Focus
Taxes Lurk Behind Court Test of Obama Health Law
Bid to Coax States On Health Exchanges
Probe into White House, PhRMA Dealings on Reform Law Continues
Healthcare Reform: GOP Preps Plan for Ruling on Law
Drug Makers Shifting Towards Targeted Cancer Drugs
'Meaningful Use' Compliance Slow
Data-Mining in Doctor's Office Helps Solve Medical Mysteries
HHS Launches Health Data Comparison Tool
FDA Concludes Safety Review Of Novartis MS Drug Gilenya
Quality of Diabetes Care No Better When Docs Use EHRs: Study
Rethinking Value-Based Health Care Delivery
FDA Puts New Limits on Oral MS Drug
Global Push to Guarantee Health Coverage Leaves U.S. Behind
Insurers Must Credit Rebates to Health Law
FDA Panel Says Yes to HIV Prevention Pill